Therefore, we suspect that MTNR1B acts as a genetic bridge between circadian rhythms and glucose metabolism, and the common variant (rs10830963) could provide predictive biomarkers and therapeutic targets for T2DM. This evidence concerns the gene MTNR1B and type 2 diabetes mellitus.